We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
MBIA
MBI
$260M
| $2.12M | ﹤0.01% |
164,984
-20,421
| -11% | -$233K |
|
2327
Bank of Marin Bancorp
BMRC
$459M
| $2.12M | ﹤0.01% |
64,419
-4,663
| -7% | -$157K |
|
|
HAYN
2328
DELISTED
Haynes International, Inc.
HAYN
| $2.11M | ﹤0.01% |
46,243
+2,057
| +5% | +$96.6K |
|
2329
NRC Health Common Stock
NRC
$450M
| $2.11M | ﹤0.01% |
56,487
-1,363
| -2% | -$52.7K |
|
2330
Tejon Ranch
TRC
$451M
| $2.11M | ﹤0.01% |
111,877
-9,438
| -8% | -$165K |
|
2331
Zumiez
ZUMZ
$339M
| $2.1M | ﹤0.01% |
96,733
-7,981
| -8% | -$177K |
|
2332
Vanguard FTSE Developed Markets ETF
VEA
$236B
| $2.1M | ﹤0.01% |
50,000
| – | – |
|
2333
Hackett Group
HCKT
$287M
| $2.1M | ﹤0.01% |
102,848
-14,108
| -12% | -$298K |
|
2334
Telos
TLS
$358M
| $2.08M | ﹤0.01% |
188,770
+51,438
| +37% | +$340K |
|
2335
Tootsie Roll Industries
TR
$2.98B
| $2.08M | ﹤0.01% |
55,045
-997
| -2% | -$36.4K |
|
|
GOOD
2336
Gladstone Commercial Corp
GOOD
$627M
| $2.08M | ﹤0.01% |
112,418
-6,748
| -6% | -$120K |
|
2337
Anika Therapeutics
ANIK
$287M
| $2.07M | ﹤0.01% |
69,792
+15,079
| +28% | +$429K |
|
2338
WisdomTree
WT
$3.22B
| $2.06M | ﹤0.01% |
378,678
-21,717
| -5% | -$113K |
|
|
TRST
2339
Trustco Bank Corp NY
TRST
$938M
| $2.06M | ﹤0.01% |
54,738
-8,673
| -14% | -$317K |
|
2340
SI-BONE Inc
SIBN
$834M
| $2.05M | ﹤0.01% |
151,037
+56,126
| +59% | +$818K |
|
2341
Anavex Life Sciences
AVXL
$310M
| $2.05M | ﹤0.01% |
221,080
-50,375
| -19% | -$538K |
|
|
SCS
2342
DELISTED
Steelcase
SCS
| $2.05M | ﹤0.01% |
289,394
-131,189
| -31% | -$970K |
|
2343
Xperi
XPER
$348M
| $2.04M | ﹤0.01% |
+237,137
| New | +$2.71M |
|
2344
Xenon Pharmaceuticals
XENE
$6.12B
| $2.02M | ﹤0.01% |
51,280
+920
| +2% | +$33.5K |
|
2345
Lemonade
LMND
$4.1B
| $2.02M | ﹤0.01% |
147,372
-20,401
| -12% | -$403K |
|
|
NWLI
2346
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $2.01M | ﹤0.01% |
7,138
-1,277
| -15% | -$272K |
|
|
SQSP
2347
DELISTED
Squarespace, Inc.
SQSP
| $2M | ﹤0.01% |
90,432
-15,498
| -15% | -$326K |
|
2348
National Healthcare
NHC
$3.38B
| $1.99M | ﹤0.01% |
33,508
-5,469
| -14% | -$332K |
|
2349
Greif Class B
GEF.B
$4.21B
| $1.99M | ﹤0.01% |
25,431
+1,408
| +6% | +$103K |
|
2350
Cass Information Systems
CASS
$743M
| $1.99M | ﹤0.01% |
43,322
-7,355
| -15% | -$308K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.